{
    "physical_examinations": [
        {
            "date": "Not specified",
            "vital_signs": "Not specified",
            "relevant_findings": "Marked dysphoria and irritability despite treatment.",
            "changes_over_time": "Initially, dysphoria and irritability persisted despite treatment; however, after adding nefazodone, there was marked improvement in mood, decreased irritability and impulsivity, better sleep, and reduced anxiety within 2 weeks."
        },
        {
            "date": "Not specified",
            "vital_signs": "Not specified",
            "relevant_findings": "Elevated carbamazepine serum levels noted.",
            "changes_over_time": "Initial serum levels between 7.0 and 8.3 µg/ml; increased to 10.8 µg/ml after nefazodone addition; required a 40% total reduction in carbamazepine due to elevated levels and side effects."
        },
        {
            "date": "Not specified",
            "vital_signs": "Not specified",
            "relevant_findings": "Diminished depth perception, sedation, slurred speech, and hypensomnia reported.",
            "changes_over_time": "Symptoms emerged after starting nefazodone at 100 mg b.i.d.; serum carbamazepine level increased to 15.1 µg/ml leading to discontinuation of nefazodone."
        }
    ]
}